The PCOS phenotype can be determined by an impaired AMH pathway mechanism by loss of target gene CYP17 inhibition, which results in an increased CYP17 level and subsequent increase in the testosterone level [178]. The gene discussed is CYP17A1; the disease is polycystic ovary syndrome.